A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant to sunitinib
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2007
At a glance
- Drugs Nilotinib (Primary) ; Imatinib
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 20 Nov 2007 New trial record.